Drugs / Flupentixol
Flupentixol
Trials 11
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00000349 | — | cocaine dependence | National Institute on Drug Abuse (NIDA) | Unknown | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT00000274 | Mar 1997 → May 1999 | cocaine dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 2 | NCT00000266 | Aug 1994 → Dec 2001 | cocaine dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 2 | NCT00000241 | Feb 1994 → May 1996 | substance-related disorder | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT03205228 | Jul 2017 → Jun 2018 | — | Mahidol University | Completed | No outcome recorded |
| Phase 3 | NCT02374567 | Jan 2015 → Jun 2017 | anxiety disorder, dementia, depressive disorder, schizophrenia +1 | Hannover Medical School | Terminated | No outcome recorded |
| Phase 3 | NCT01765829 | Nov 2012 → Nov 2015 | psychotic disorder | Fundación Pública Andaluza Progreso y Salud | Unknown | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT06927375 | Dec 2024 → Nov 2025 overdue | disease of orbital part of eye adnexa | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Recruiting | No outcome recorded |
| Phase 4 | NCT04898270 | Dec 2019 → Dec 2020 | metabolic syndrome X, schizophrenia | Taichung Veterans General Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04970667 | Jan 2018 → Jan 2020 | mood disorder | Peking University Third Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial · 1 met primary | ||||||
| — | NCT05099913 | Aug 2020 → Oct 2022 | drug-induced mental disorder, dyspepsia, substance withdrawal syndrome | RenJi Hospital | Unknown | Met primary |
| Comparator or background therapy5 trials | ||||||
| Phase 2 | NCT01323205 Background | May 2011 → Nov 2012 | schizophrenia | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 2 | NCT00000275 Background | Nov 1996 → Mar 1998 | substance-related disorder | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 4 | NCT01851863 Comparator | May 2013 → Jun 2014 | depressive disorder, dyspepsia | RenJi Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01164059 Comparator | Feb 2010 → Aug 2013 | schizophrenia | University of Bremen | Completed | Mixed |
| — | NCT06756139 Comparator | Nov 2024 → Nov 2025 overdue | dyspepsia | Air Force Military Medical University, China | Recruiting | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 18 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flupentixol | “Regular antipsychotic medications (Risperidone, Olanzapine, Clozapine, Amisulpride, Quetiapine, Paliperidone, Aripiprazole, Haloperidol, Levomepromazine, Zuclopenthixol...” NCT01323205 ↗10“Drugs: Aripiprazole, Olanzapine, Zuclopenthixol, Clotiapine, Flupentixol, Risperidone, Sulpiride, Trifluoperazine, Haloperidol, Quetiapine, Paliperidone, Chlorpromazine,...” NCT01765829 ↗ “Flupentixol and Melitracen” NCT05099913 ↗ |
| Known as | Flupenthixol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000274 ↗ |
| Known as | Flupentixol dihydrochloride | “The active components of Deanxit are Flupentixol dihydrochloride (Flupentixol) and melitracen (melitracen).” NCT04970667 ↗ |
| Known as | LC 44 | ChEMBL registry synonym — accepted as the source's own label CHEMBL6066864 ↗ |
| Known as | N-7009 | ChEMBL registry synonym — accepted as the source's own label CHEMBL6066864 ↗ |
| Route | Oral | “haloperidol [3-6 mg] or flupentixol [6-12 mg]) given orally” PMID 27265548 ↗ Jun 2016 |